F Boccardo

Summary

Affiliation: University of Genoa
Country: Italy

Publications

  1. ncbi Intracystic epidermal growth factor level is predictive of breast-cancer risk in women with gross cystic disease of the breast
    F Boccardo
    Professorial Unit of Medical Oncology, National Cancer Research Institute, Genoa, Italy
    Int J Cancer 95:260-5. 2001
  2. ncbi Sequential tamoxifen and aminoglutethimide versus tamoxifen alone in the adjuvant treatment of postmenopausal breast cancer patients: results of an Italian cooperative study
    F Boccardo
    Professorial Unit of Medical Oncology, University and National Cancer Research Institute, Largo R Benzi 10, 16132 Genoa, Italy
    J Clin Oncol 19:4209-15. 2001
  3. ncbi Management of breast cancer: is there a role for somatostatin and its analogs?
    F Boccardo
    Academic Unit of Medical Oncology, National Cancer Institute, Genoa, Italy
    Chemotherapy 47:62-77. 2001
  4. ncbi Switching to anastrozole versus continued tamoxifen treatment of early breast cancer. Updated results of the Italian tamoxifen anastrozole (ITA) trial
    F Boccardo
    The National Cancer Research Institute and the University of Genoa, Genoa, Italy
    Ann Oncol 17:vii10-4. 2006
  5. ncbi Lymphatic microsurgery for the treatment of lymphedema
    C Campisi
    Section of Lymphatic Surgery and Microsurgery, Department of Surgery, S Martino Hospital, University of Genoa, Genoa, Italy
    Microsurgery 26:65-9. 2006
  6. ncbi Adjuvant chemotherapy with high-dose cyclophosphamide, etoposide and cisplatin intensification without progenitor cell support in breast cancer patients with ten or more involved nodes: 5-year results of a pilot trial
    A Ballestrero
    Department of Internal Medicine, Intensive Chemo-Immunotherapy Unit, University of Genoa, Genoa, Italy
    Oncology 60:221-7. 2001
  7. ncbi Paclitaxel by 72-hour continuous infusion followed by bolus intravenous ifosfamide or epirubicin: results of two phase I studies
    L Miglietta
    Professorial Unit of Medical Oncology, University and National Cancer Institute, University of Genoa, Italy
    Oncology 60:116-22. 2001
  8. ncbi General surgery, translational lymphology and lymphatic surgery
    C Campisi
    Unit of Lymphatic Surgery, Department of Surgery, IRCCS University Hospital S Martino IST, National Institute for, Cancer Research, University of Genoa, Genoa, Italy
    Int Angiol 30:504-21. 2011
  9. ncbi The role of lymphoscintigraphy in the diagnosis of lymphedema in Turner syndrome
    C Bellini
    Neuromuscular Diseases Unit, Department of Pediatrics, University of Genoa, Genoa, Italy
    Lymphology 42:123-9. 2009
  10. ncbi Evaluation of tamoxifen and anastrozole in the prevention of gynecomastia and breast pain induced by bicalutamide monotherapy of prostate cancer
    F Boccardo
    University and National Cancer Research Institute, University of Genoa, Genoa, Italy
    J Clin Oncol 23:808-15. 2005

Detail Information

Publications41

  1. ncbi Intracystic epidermal growth factor level is predictive of breast-cancer risk in women with gross cystic disease of the breast
    F Boccardo
    Professorial Unit of Medical Oncology, National Cancer Research Institute, Genoa, Italy
    Int J Cancer 95:260-5. 2001
    ..Our results confirm that women affected by palpable cysts have an increased risk of developing breast cancer and suggest that the risk is higher in women with high intracystic EGF concentrations...
  2. ncbi Sequential tamoxifen and aminoglutethimide versus tamoxifen alone in the adjuvant treatment of postmenopausal breast cancer patients: results of an Italian cooperative study
    F Boccardo
    Professorial Unit of Medical Oncology, University and National Cancer Research Institute, Largo R Benzi 10, 16132 Genoa, Italy
    J Clin Oncol 19:4209-15. 2001
    ..To determine whether switching patients from tamoxifen to antiaromatase treatment would prevent some of the relapses or deaths that we assume would occur if tamoxifen were continued...
  3. ncbi Management of breast cancer: is there a role for somatostatin and its analogs?
    F Boccardo
    Academic Unit of Medical Oncology, National Cancer Institute, Genoa, Italy
    Chemotherapy 47:62-77. 2001
    ..The reasons for the limited efficacy shown by these compounds either when used alone or when used in combination with other drugs have also been critically reviewed in the perspective of new trials...
  4. ncbi Switching to anastrozole versus continued tamoxifen treatment of early breast cancer. Updated results of the Italian tamoxifen anastrozole (ITA) trial
    F Boccardo
    The National Cancer Research Institute and the University of Genoa, Genoa, Italy
    Ann Oncol 17:vii10-4. 2006
    ..Moreover, many women relapse during or after tamoxifen therapy due to the development of resistance. This provided the rationale for a switching trial with anastrozole, the updated results of which are reported here...
  5. ncbi Lymphatic microsurgery for the treatment of lymphedema
    C Campisi
    Section of Lymphatic Surgery and Microsurgery, Department of Surgery, S Martino Hospital, University of Genoa, Genoa, Italy
    Microsurgery 26:65-9. 2006
    ..Improved results can be expected with operations performed earlier at the very first stages of lymphedema...
  6. ncbi Adjuvant chemotherapy with high-dose cyclophosphamide, etoposide and cisplatin intensification without progenitor cell support in breast cancer patients with ten or more involved nodes: 5-year results of a pilot trial
    A Ballestrero
    Department of Internal Medicine, Intensive Chemo-Immunotherapy Unit, University of Genoa, Genoa, Italy
    Oncology 60:221-7. 2001
    ..Although this regimen does not require stem cell harvesting and storage, it requires clinical support comparable to autotransplantation procedures and side effects are not so manageable to recommend its use outside specialized units...
  7. ncbi Paclitaxel by 72-hour continuous infusion followed by bolus intravenous ifosfamide or epirubicin: results of two phase I studies
    L Miglietta
    Professorial Unit of Medical Oncology, University and National Cancer Institute, University of Genoa, Italy
    Oncology 60:116-22. 2001
    ..The optimal way to combine paclitaxel and epirubicin and the best schedule relative to such a long paclitaxel infusion time in this combination regimen remain to be determined...
  8. ncbi General surgery, translational lymphology and lymphatic surgery
    C Campisi
    Unit of Lymphatic Surgery, Department of Surgery, IRCCS University Hospital S Martino IST, National Institute for, Cancer Research, University of Genoa, Genoa, Italy
    Int Angiol 30:504-21. 2011
    ..Thus, strategies of treatment were proposed to prevent lymphatic injuries, to avoid lymphatic complications and to treat lymphatic diseases early in order to be able even to cure these pathologies...
  9. ncbi The role of lymphoscintigraphy in the diagnosis of lymphedema in Turner syndrome
    C Bellini
    Neuromuscular Diseases Unit, Department of Pediatrics, University of Genoa, Genoa, Italy
    Lymphology 42:123-9. 2009
    ....
  10. ncbi Evaluation of tamoxifen and anastrozole in the prevention of gynecomastia and breast pain induced by bicalutamide monotherapy of prostate cancer
    F Boccardo
    University and National Cancer Research Institute, University of Genoa, Genoa, Italy
    J Clin Oncol 23:808-15. 2005
    ..To determine whether tamoxifen or anastrozole prevents gynecomastia and breast pain caused by bicalutamide (150 mg) without compromising efficacy, safety, or sexual functioning...
  11. ncbi Interleukin-2, interferon-alpha and interleukin-2 plus interferon-alpha in renal cell carcinoma. A randomized phase II trial
    F Boccardo
    Department of Medical Oncology II, National Institute for Cancer Research, Genoa, Italy
    Tumori 84:534-9. 1998
    ..This stresses the need for the development of new approaches...
  12. ncbi Estramustine phosphate (estracyt) following androgens in men with refractory stage D2 prostate cancer
    F Boccardo
    Department of Clinical Oncology, National Cancer Institute, Genova, Italy
    Cancer Chemother Pharmacol 22:172-4. 1988
    ..In this group of patients, androgen priming did not seem to potentiate the effectiveness of EMP, our results being comparable to those previously reported using EMP alone...
  13. ncbi Perinatal deaths and lymphatic system involvement: a diagnostic flow-chart applying immunohistochemical methods
    C Bellini
    Neonatal Intensive Care Unit, Department of Pediatrics, University of Genoa, I R C C S Gaslini Institute, Genoa, Italy
    Lymphology 44:131-3. 2011
    ..Immunohistochemical staining with CD-31, CD-34, D2-40, and smooth muscle actin is recommended...
  14. ncbi 4-OH tamoxifen does not interfere with bicalutamide inhibitory effects on human prostatic cancer cells in vitro
    F Boccardo
    University of Genoa, Italy
    Anticancer Res 25:4277-80. 2005
    ..The present study was aimed at investigating the effects of the co-administration of 4-OH Tamoxifen (4HT) and bicalutamide (BIC) on the human prostate cancer cell line LNCaP in vitro...
  15. ncbi Influence of bicalutamide with or without tamoxifen or anastrozole on insulin-like growth factor 1 and binding proteins in prostate cancer patients
    F Boccardo
    Department of Medical Oncology, National Cancer Research Institute and University of Genoa, Italy
    Int J Biol Markers 21:123-6. 2006
    ..There is growing evidence that IGF-1 and binding proteins may be involved in prostate cancer promotion and progression...
  16. ncbi The use of vein grafts in the treatment of peripheral lymphedemas: long-term results
    C Campisi
    Department of Specialistic Surgical Sciences, Anaesthesiology and Organ Transplants DISCAT, Emergency Surgical Clinic Section, Lymphology and Microsurgery Center, S Martino Hospital, University of Genoa, 16122 Genoa, Italy
    Microsurgery 21:143-7. 2001
    ..The new aspect of the study is that we report long-term clinical and instrumental results...
  17. ncbi Vein graft interposition in treating peripheral lymphoedemas
    C Campisi
    Department of Specialistic Surgical Sciences, Anaesthesiology and Organ Transplants, Emergency Surgical Clinic Section, Lymphology and Microsurgery Centre, S Martino Hospital, University of Genoa, Italy
    Handchir Mikrochir Plast Chir 35:221-4. 2003
    ..This technique of interposed vein grafts allows peripheral lymphoedemas to be treated when derivative lympho-venous shunts can not be used due to an impaired venous circulation in the same lymphoedematous limb...
  18. ncbi Lymphedema and microsurgery
    C Campisi
    Department of Specialist Surgical Sciences, Anesthesiology and Organ Transplants, Lymphology and Microsurgery Center, St Martino s Hospital, University of Genoa, Largo Rosanna Venzi 8, 16132 Genoa, Italy
    Microsurgery 22:74-80. 2002
    ..This article systematically reviews the published literature on the microsurgical treatment of lymphedema to the present...
  19. ncbi [Lymphedema secondary to breast cancer treatment: possibility of diagnostic and therapeutic prevention]
    C Campisi
    Universita degli Studi di Genova, Dipartimento di Scienze Chirurgiche Specialistiche, Anestesiologia e Trapianti d Organo DI S C A T Sezione di Clinica Chirurgica d Urgenza, Centro di Linfologia e Microchirurgia, Ospedale S Martino
    Ann Ital Chir 73:493-8. 2002
    ....
  20. ncbi Long-term results after lymphatic-venous anastomoses for the treatment of obstructive lymphedema
    C Campisi
    Department of Specialistic Surgical Sciences, Anaesthesiology and Organ Transplants DISCAT, Emergency Surgical Clinic Section, Lymphology and Microsurgery Center, S Martino Hospital, University of Genoa, 16122 Genoa, Italy
    Microsurgery 21:135-9. 2001
    ..Improved results can be expected with earlier operations because patients referred earlier usually have fewer lymphatic alterations...
  21. ncbi [Post-mastectomy lymphedema: surgical therapy]
    C Campisi
    Dipartimento di Scienze Chirurgiche Specialistiche, Anestesiologia e Trapianti d Organo DISCAT, Sezione di Clinica Chirurgica d Urgenza, Centro di Linfologia e Microchirurgia, Ospedale S Martino, Universita degli Studi di Genova
    Ann Ital Chir 73:473-8. 2002
    ..The registry consists of 194 microsurgical operations, performed in patients treated and followed-up statistically in the last 15 years, with positive result in over 80% of cases...
  22. ncbi R75251 in prostate cancer patients in progression after first-line hormonal treatment
    F Boccardo
    Department of Medical Oncology II, National Institute for Cancer Research, Genoa, Italy
    Tumori 80:276-9. 1994
    ....
  23. ncbi Congenital lymphatic dysplasias: genetics review and resources for the lymphologist
    C Bellini
    Neuromuscular Diseases Unit, Department of Pediatrics, University of Genoa, G Gaslini Institute, Genoa, Italy
    Lymphology 42:36-41. 2009
    ..These tools are a way of identifying lymphatic dysplasias at a very early stage...
  24. ncbi Prevalence of oedema of the lower limbs in multiple sclerosis patients: a vascular and lymphoscintigraphic study
    C Solaro
    Department of Neurology, PA Micone Hospital, Genoa, Italy
    Mult Scler 12:659-61. 2006
    ..Lower limb oedema is common in MS patients, especially in those with reduced mobility. Early screening is advised in patients with an elevated EDSS...
  25. ncbi Functional magnetic resonance evidence of cortical alterations in a case of reversible congenital lymphedema of the lower limb: a pilot study
    M Pardini
    Magnetic Resonance Research Centre on Nervous System Diseases, University School of Medicine and Surgery, San Martino Hospital, Genoa, Italy
    Lymphology 40:19-25. 2007
    ..We suggest that these alterations could be related to changes in body schema representation due to the congenital lymphedema...
  26. ncbi Is there a role for microsurgery in the prevention of arm lymphedema secondary to breast cancer treatment?
    C Campisi
    Section of Lymphatic Surgery and Microsurgery, Department of Surgery, S. Martino Hospital, University of Genoa, Genoa, Italy
    Microsurgery 26:70-2. 2006
    ..01, using Fisher's exact test). The diagnostic and therapeutic preventive procedures allow to reduce the incidence rate of lymphedema significantly, in comparison with patients who did not undergo this protocol of prevention...
  27. ncbi Serum enterolactone levels and the risk of breast cancer in women with palpable cysts
    F Boccardo
    Academic Department of Medical Oncology, National Cancer Research Institute, Largo Rosanna Benzi 10, 16132 Genoa, Italy
    Eur J Cancer 40:84-9. 2004
    ..These findings may have important clinical implications with regard to interventional diet-focused chemo-preventive trials...
  28. ncbi Italian national consensus conference on prostate cancer screening (Florence, May 17, 2003)--final consensus document
    F Boccardo
    Department of Medical Oncology, National Cancer Institute, Genoa, Italy
    Int J Biol Markers 18:238-40. 2003
  29. ncbi Combined treatment with chemotherapy and radiotherapy in high-risk FIGO stage III-IV endometrial cancer patients
    M Bruzzone
    Medical Oncology Unit C, National Cancer Research Institute, Genoa, Italy
    Gynecol Oncol 93:345-52. 2004
    ..We reviewed our series of very advanced FIGO stage III-IV endometrial cancer patients to assess the efficacy and toxicity of a platinum- and doxorubicin-containing chemotherapy followed by conventional radiotherapy...
  30. ncbi Adjuvant chemotherapy of bladder cancer
    F Boccardo
    National Cancer Research Institute and University of Genoa, Genoa, Italy
    Ann Oncol 17:v129-32. 2006
    ..Optimal treatment for high risk patients includes local and perioperative systemic therapy (adjuvant or neoadjuvant chemotherapy)...
  31. ncbi Guidelines of the Societá Italiana di Linfangiologia: excerpted sections
    C Campisi
    University School of Medicine and Surgery, San Martino Hospital, Department of Surgery-Section of Lymphatic Surgery and Microsurgery, Genoa, Italy
    Lymphology 37:182-4. 2004
  32. ncbi Ifosfamide in urologic cancer
    F Boccardo
    Academic Department of Medical Oncology, Medical Oncology B, National Cancer Research Institute and University of Genoa, Genoa, Italy
    Oncology 65:67-72. 2003
    ..No results of ifosfamide in penile carcinoma are available so far...
  33. ncbi Combined tamoxifen and luteinizing hormone-releasing hormone (LHRH) agonist versus LHRH agonist alone in premenopausal advanced breast cancer: a meta-analysis of four randomized trials
    J G Klijn
    Dr Daniel den Hoed Kliniek and University Hospital, Rotterdam, The Netherlands
    J Clin Oncol 19:343-53. 2001
    ..Therefore, if a premenopausal woman with advanced breast cancer is thought to be suitable for endocrine treatment, it is proposed that the combination of a LHRH agonist plus tamoxifen be considered as the new standard treatment...
  34. ncbi [Disability and lymphedema]
    F Boccardo
    Dipartimento di Scienze Chirurgiche Specialistiche, Anestesiologia e Trapianti d'Organo (DISCAT, Sezione di Clinica Chirurgica d'Urgenza, Centro di Linfologia e Microchirurgia, Ospedale S. Martino,
    Ann Ital Chir 73:485-8. 2002
    ..Finally, therapeutic and preventive procedures are pointed out with the aim of reducing the psycho-physical burden of disability correlated to lymphedema...
  35. ncbi Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial
    Robert J Motzer
    Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Lancet 372:449-56. 2008
    ..We did a phase III, randomised, double-blind, placebo-controlled trial of everolimus in patients with metastatic renal cell carcinoma whose disease had progressed on vascular endothelial growth factor-targeted therapy...
  36. ncbi Diagnostic protocol for lymphoscintigraphy in newborns
    C Bellini
    Servizio di Patologia Neonatale, Dipartimento di Pediatria DIPE, Universita di Genova, Istituto G Gaslini, Italy
    Lymphology 38:9-15. 2005
    ..Indications for lymphoscintigraphy, choice of tracer, optimal dose, routes of administration, methods of data acquisition, timing, and interpretation of results for newborns are presented and discussed...
  37. ncbi Lymphodynamics in the fetus and newborn
    C Bellini
    Servizio di Patologia Neonatale, Dipartimento di Pediatria, Universita di Genova, Istituto G Gaslini, Genova, Italy
    Lymphology 39:110-7. 2006
    ....
  38. ncbi Multimodal imaging in the congenital pulmonary lymphangiectasia-congenital chylothorax-hydrops fetalis continuum
    C Bellini
    Servizio di Patologia Neonatale, Dipartimento di Pediatria, Universita di Genova, Istituto G Gaslini, Genova, Italia
    Lymphology 37:22-30. 2004
    ..Non-Immune Hydrops Fetalis (NIHF) may be the final consequence of impaired systemic venous return and may help to explain pleural-pulmonary involvement in this generalized lymph-vessel malformation syndrome...
  39. ncbi Phase II study with lonidamine in the treatment of hormone-refractory prostatic cancer patients
    F Boccardo
    Servizio di Oncologia Medica II, Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy
    Tumori 78:137-9. 1992
    ..We conclude that this therapeutic approach with lonidamine is not active in hormone-refractory prostatic cancer patients with distant metastasis...
  40. ncbi A phase II trial with cisplatin-paclitaxel cytotoxic treatment and concurrent external and endocavitary radiation therapy in locally advanced or recurrent cervical cancer
    L Miglietta
    Istituto Nazionale per la Ricerca sul Cancro, Genova, Italia
    Oncology 70:19-24. 2006
    ....
  41. ncbi Lusorian artery simulating rheumatic diseases
    M G Alpigiani
    Clin Exp Rheumatol 21:411. 2003